These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6384690)

  • 21. Transfusion-associated graft-versus-host disease.
    Dwyre DM; Holland PV
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion associated graft versus host disease.
    Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
    J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case report of graft-versus-host disease caused by using stored blood after aortic valve replacement].
    Hara Y; Morimoto K; Nakamura Y; Sasaki S; Kuroda H; Mori T; Tanaka K; Nishikawa K
    Kyobu Geka; 1993 May; 46(5):438-41. PubMed ID: 8492500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
    Huss R; Deeg HJ; Gooley T; Bryant E; Leisenring W; Clift R; Buckner CD; Martin P; Storb R; Appelbaum FR
    Bone Marrow Transplant; 1996 Oct; 18(4):767-76. PubMed ID: 8899193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of fatal graft-versus-host disease following blood transfusion in esophageal cancer documented by homozygous changes of HLA typing].
    Soeda K; Onoda S; Kozu T; Okuyama K; Koide Y; Isono K
    Nihon Geka Gakkai Zasshi; 1990 Aug; 91(8):1040-3. PubMed ID: 2233658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Graft versus host disease after transfusion of blood and its products].
    Molaro GL; De Angelis V
    Riv Emoter Immunoematol; 1984; 31(2):107-23. PubMed ID: 6399156
    [No Abstract]   [Full Text] [Related]  

  • 28. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients.
    Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M
    Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological mechanisms in aplastic anemia. III. Arguments against the role of primary immunologic disorders in aplastic anemia: effect of transfusion of blood components on the course of aplastic anemia].
    Rupniewska ZM; Dmoszyńska-Giannopoulos A
    Przegl Lek; 1982; 39(12):821-3. PubMed ID: 6762620
    [No Abstract]   [Full Text] [Related]  

  • 30. Transfusion induced Graft versus host disease - Case report in a 2 year child.
    Naveen KN; Kabbin GM; Kulkarni V; Pai VV; Rao R
    Transfus Apher Sci; 2012 Aug; 47(1):17-9. PubMed ID: 22475546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic granulocyte transfusions.
    Buckner CD; Clift RA; Sanders JE; Hersman JA; Williams B
    Prog Clin Biol Res; 1982; 88():93-100. PubMed ID: 6285388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfusion-associated graft-versus-host disease in severe combined immunodeficiency.
    Sebnem Kilic S; Kavurt S; Balaban Adim S
    J Investig Allergol Clin Immunol; 2010; 20(2):153-6. PubMed ID: 20461970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of bone marrow aplasia by allogenic bone marrow grafts].
    Gluckman E; Bussel A; Benbunan M; Broquet MA; Schaison G; Dausset J; Bernard J
    Nouv Presse Med; 1975 Apr; 4(16):1177-82. PubMed ID: 240152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Post-transfusion graft versus host disease in a patient with Hodgkin's disease].
    Tomás Martínez JF; Abad Hernández MJ; Cortina de la Calle MP; Canut Blasco A; Nieto González MJ; Corral Alonso M; San Miguel Izquierdo JF; López-Borrasca A
    Med Clin (Barc); 1989 Apr; 92(13):503-6. PubMed ID: 2747313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aplastic anemia complicated with ulcerative colitis].
    Shimada T; Maeda T; Ishikawa M; Okamura D; Ito Y; Wakimoto N; Nakamura Y; Kawai N; Ino H; Jinnai I; Mori S; Matsuda A; Bessho M
    Rinsho Ketsueki; 2012 Feb; 53(2):224-8. PubMed ID: 22450583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia.
    Novitzky N; Thomas V; du Toit C
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):584-8. PubMed ID: 23270985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature.
    Decoste SD; Boudreaux C; Dover JS
    Arch Dermatol; 1990 Oct; 126(10):1324-9. PubMed ID: 2221937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-I-associated myelopathy following allogeneic bone marrow transplantation.
    Emmanouilides CE; Territo M
    Bone Marrow Transplant; 1999 Jul; 24(2):205-6. PubMed ID: 10455351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.